Test Bank For Pharmacotherapeutics For Advanced Practice Nurse Prescribers 5th Edition by Teri Moser Woo, Marylou Robinson..pdf

Test Bank: Pharmacotherapeutics for Advanced Practic
m m m m m




e Nurse Prescribers, 5th Edition, Teri Moser Woo, Maryl
m m m m m m m m




ou

Pharmacotherapeutics for Advanced P m m m




ractice Nurse Prescribers 5th EditionW
m m m m m




oo Robinson Test Bank
m m m

,Test Bank: Pharmacotherapeutics for Advanced Practic
m m m m m




e Nurse Prescribers, 5th Edition, Teri Moser Woo, Maryl
m m m m m m m m




ou
PharmacotherapeuticsmformAdvancedmPracticemNursemPrescribersm5thmEditionmWoomRobinsonmTest mBank


Chapterm1.mThemRolemof mthemNursemPractition

ermMultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersm themquestion.

m mmm 1.mNursempractitionermprescriptivemauthoritymismregulated m by:
1. ThemNationalmCouncilmof mStatemBoardsmof mNursing
2. ThemU.S.mDrugmEnforcement mAdministration
3. ThemStatemBoard mof mNursingmformeachmstate
4. ThemStatemBoard mof mPharmacy
m

mmm2.mThembenefitsmtomthempatient mof mhavingmanmAdvanced mPracticemRegistered mNursem(APRN)m

prescriberminclude:
1. Nursesmknow mmoremabout mPharmacologymthanmothermprescribersmbecausemtheymtake
mit m
bothminmtheirmbasicmnursingmprogrammand minmtheirmAPRN mprogram.
2. Nursesmcaremformthempatient mfrommamholisticmapproachmand mincludemthempatient
minm decisionmmakingmregardingmtheirmcare.
3. APRNsmaremlessmlikelymtomprescribemnarcoticsmand mothermcontrolled msubstances.
4. APRNsmaremablemtomprescribemindependentlyminmallmstates,mwhereasmamphysicia
n’smassistant mneedsmtomhavemamphysicianmsupervisingmtheirmpractice.
m mmm 3.mClinicalmjudgment minmprescribingm includes:
1. Factoringminmthemcost mtomthempatient mof mthemmedicationmprescribed
2. Alwaysmprescribingmthemnewest mmedicationmavailablemformthemdiseasemprocess
3. Handingmout mdrugmsamplesmtompoormpatients
4. Prescribingmallmgenericmmedicationsmtomcut mcosts

m mmm 4.mCriteriamformchoosingmanmeffectivemdrugmformamdisorderm include:
1. Askingmthempatient mwhat mdrugmtheymthinkmwould mworkmbest mformthem
2. Consultingmnationallymrecognized mguidelinesmformdiseasemmanagement
3. Prescribingmmedicationsmthat maremavailablemasmsamplesmbeforemwritingmamprescription
4. FollowingmU.S.mDrugmEnforcement mAdministrationmguidelinesmformprescribing

m mmm 5.mNursempractitionermpracticemmaymthrivemundermhealth-caremreform mbecause mof:
1. Themdemonstrated mabilitymof mnursempractitionersmtomcontrolmcostsmand mimprovempatie
nt moutcomes
2. Themfact mthat mnursempractitionersmwillmbemablemtompracticemindependently
3. Themfact mthat mnursempractitionersmwillmhavemfullmreimbursement mundermhealth-
caremreform
4. Themabilitymtomshift maccountabilitymformMedicaid mtomthemstatemlevel

,Test Bank: Pharmacotherapeutics for Advanced Practic
m m m m m




e Nurse Prescribers, 5th Edition, Teri Moser Woo, Maryl
m m m m m m m m




ou

, Test Bank: Pharmacotherapeutics for Advanced Practic
m m m m m




e Nurse Prescribers, 5th Edition, Teri Moser Woo, Maryl
m m m m m m m m




ou
Chapterm1.mThemRolemof mthemNursemPractition
ermAnswermSection

MULTIPLEmCHOICE

1. ANS:mmm 3 PTS:m 1
2. ANS:mmm 2 PTS:m 1
3. ANS:mmm 1 PTS:m 1
4. ANS:mmm 2 PTS:m 1
5. ANS:mmm 1 PTS:m 1

Chapterm2.mReview mof mBasicmPrinciplesmof mPharmacolo

gymMultiplemChoice
Identifymthemchoicemthatmbestmcompletesmthemstatementmormanswersm themquestion.

m

mmm1.mA mpatient’smnutritionalmintakemand mlaboratorymresultsmreflect mhypoalbuminemia.m Thism ism

criticalmtomprescribingmbecause:
1. Distributionmof mdrugsmtomtarget mtissuemmaymbemaffected.
2. Themsolubilitymof mthemdrugmwillmnot mmatchmthemsitemof mabsorption.
3. Theremwillmbemlessmfreemdrugmavailablemtomgeneratemanmeffect.
4. Drugsmbound mtomalbuminmaremreadilymexcreted mbymthemkidneys.

m mmm 2.mDrugsmthat mhavemamsignificant mfirst-passm effect:
1. Must mbemgivenmbymthementeralm(oral)mroutemonly
2. Bypassmthemhepaticmcirculation
3. Aremrapidlymmetabolized mbymthemlivermand mmaymhavemlittlemif manymdesired maction
4. Aremconverted mbymthemlivermtommoremactivemand mfat-solublemforms

m mmm 3.mThemroutemof mexcretionmof mamvolatilemdrugmwillmlikelymbe mthe:
1. Kidneys
2. Lungs
3. Bilemand mfeces
4. Skin
m

mmm4.mMedroxyprogesteronem(DepomProvera)mismprescribed mintramuscularlym(IM)mtomcreatem

amstoragemreservoirmof mthemdrug.mStoragemreservoirs:
1. Assuremthat mthemdrugmwillmreachmitsmintended mtarget mtissue
2. Aremthemreasonmformgivingmloadingmdoses
3. Increasemthemlengthmof mtimemamdrugmismavailablemand mactive
4. Aremmost mcommonminmcollagenmtissues

m mmm 5.mThemNPmchoosesmtomgivemcephalexinmeverym8mhoursmbased monmknowledgemof mthemdrug’s:
1. Propensitymtomgomtomthemtarget mreceptor
2. Biologicalmhalf-life
3. Pharmacodynamics
4. Safetymand msidemeffects